Another US warning on Indian drugs

US FDA India head gives more examples of lax quality here; urges firms to put onus on quality

The US Food and Drug Administration (FDA) wants Indian drug manufacturers to get their act together, citing instances of sale of drugs which lack the stated content and complaints of medicines not delivering desired results.

FDA's India office director Matthew Thomas highlighted his concerns at an Indian Pharmaceutical Alliance (IPA) gathering herre. "I had the opportunity to test some of the products with a rapid test tool. I got a blister pack of paracetamol and the test showed there was no drug in it," he stated.

Thomas said he occasionally got samples from the US embassy's health unit in Delhi and the